Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds (Q58696993)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds |
article |
Statements
Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds (English)
Rime Bahij El-Houri
22 September 2018
9 references
13 March 2019
14 March 2019
24 March 2019
19 September 2019
21 December 2019
27 October 2020
4 February 2021
22 August 2022
8 references
13 March 2019
14 March 2019
24 March 2019
19 September 2019
21 December 2019
27 October 2020
4 February 2021
2431
0 references
8 references
13 March 2019
14 March 2019
24 March 2019
19 September 2019
21 December 2019
27 October 2020
4 February 2021
22 August 2022
1 reference
1 reference
1 reference